Patrick Lacor

2.6k citations
78 papers · 2k · 1 hit paper · h-index 25

Impact in

Papers in

    • HIV/AIDS Research and Interventions 15
    • HIV/AIDS drug development and treatment 4
    • Multiple Myeloma Research and Treatments 5
    • Acute Myeloid Leukemia Research 3

Patrick Lacor

71 papers receiving 2k citations

Patrick Lacor's Hit Papers

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 2018 · 313 citations
3130+2+5Years since publication100200300

Peers

Patrick Lacor
Comparison fields: 5 of 106
  • Applied Microbiology and Biotechnology 163
  • Virology 195
  • Infectious Diseases 638
  • Hematology 336
  • Emergency Medical Services 129
Replace Michael H. Augenbraun with:
Michael H. Augenbraun United States
Kiran M. Perkins United States
Desireé Caselli Italy
Eoghan de Barra Ireland
Davide Mangioni Italy
Paul S. Pottinger United States
Sophie Abgrall France
Elham Khatamzas Germany
Matthew J. Hepburn United States
É. Rouveix France
Patrick Lacor relative to Michael H. Augenbraun United States Michael H. Augenbraun's profile →
Citations per field
00.5×2×4×6×8.6×
Michael H. Augenbraun · 1×
Citations per year

Countries citing papers authored by Patrick Lacor

Since Specialization
Citations

This map shows the geographic impact of Patrick Lacor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Lacor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Lacor more than expected).

Fields of papers citing papers by Patrick Lacor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Lacor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Lacor. The network helps show where Patrick Lacor may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Lacor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Lacor Line = papers co-authored together Patrick Lacor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
2 2004144
3 2016105
4 2018103
5 201198
6 199696
7 199190
8
The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
199690
9 201559
10 198956
11 201855
12 200750
13 201650
14 199843
15 201141
16 199935
17 199631
18 200831
19 201231
20 200430

About Patrick Lacor

Patrick Lacor is a scholar working on Infectious Diseases, Hematology, Virology, Applied Microbiology and Biotechnology and Epidemiology, having authored 78 papers that have together received 2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (15 papers), HIV Research and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers), Antibiotic Use and Resistance (5 papers), HIV/AIDS drug development and treatment (4 papers), Acute Myeloid Leukemia Research (3 papers), Respiratory viral infections research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (163 citations), Virology (195 citations), Infectious Diseases (638 citations), Hematology (336 citations) and Emergency Medical Services (129 citations). Patrick Lacor has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Johan J.R. Bilsen, Reginald Deschepper, Ivan Van Riet, M. De Waele, Rik Schots, B Van Camp, Benjamin Van Camp, Sabine Danielle Allard, Christel Fontaine and Sabine Lauwers. Their work appears in journals such as European Journal of Internal Medicine, British Journal of Haematology, European Journal Of Haematology, The Lancet and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact